Arianna Loregian, Giorgio Palù
While the pharmaceutical industry is facing highly challenging times, the academic drug discovery sector has the potential to contribute meaningfully to the discovery of novel drug targets and to the development of new mode-of-action therapeutics against a range of diseases, including rare and neglected diseases.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados